13423-22-8

Usage

Uses

Used in Pharmaceutical Industry:
2-Azetidinone, 3,3,4,4-tetramethylis used as a building block and intermediate for the synthesis of various pharmaceuticals. It plays a crucial role in the development of new drugs and medicines.
Used in Agrochemical Industry:
2-Azetidinone, 3,3,4,4-tetramethylis also used as a building block and intermediate in the synthesis of various agrochemicals. It helps in the development of new pesticides and other agricultural chemicals.
Used in Polymer Production:
2-Azetidinone, 3,3,4,4-tetramethylis utilized in the production of polymers. It contributes to the development of new polymer materials with specific properties and applications.
Used as a Chiral Auxiliary in Organic Synthesis:
2-Azetidinone, 3,3,4,4-tetramethylserves as a chiral auxiliary in organic synthesis. It helps in the synthesis of enantiomerically pure compounds, which are important in various chemical and pharmaceutical applications.
Used in Research and Development:
2-Azetidinone, 3,3,4,4-tetramethylis used as an intermediate in the synthesis of various compounds for research and development purposes. It aids in the discovery and development of new chemical entities and their potential applications.

Upstream product

• 1189-71-5 isocyanate de chlorosulfonyle 
• 563-79-1 2,3-Dimethyl-2-butene 
• 17060-95-6 1-chlorosulfonyl-3,3,4,4-tetramethyl-2-azetidinone 

Downstream Products

• 22607-03-0 1-benzyl-3,3,4,4-tetramethylazetidin-2-one 
• 128694-17-7 5-Ethoxy-6,6,7,7-tetramethyl-2-phenyl-4-oxa-1,3-diaza-bicyclo[3.2.0]hept-2-ene 
• 128694-20-2 2-Phenyl-5-ethylthio-6,6,7,7-tetramethyl-4-oxa-1,3-diazabicyclo[3.2.0]hept-2-ene 
• 128694-16-6 5-Ethoxy-2-(4-methoxy-phenyl)-6,6,7,7-tetramethyl-4-oxa-1,3-diaza-bicyclo[3.2.0]hept-2-ene 
• 128694-18-8 5-Ethoxy-6,6,7,7-tetramethyl-2-(2-nitro-phenyl)-4-oxa-1,3-diaza-bicyclo[3.2.0]hept-2-ene 
• 128694-21-3 5-Ethylsulfanyl-6,6,7,7-tetramethyl-2-(2-nitro-phenyl)-4-oxa-1,3-diaza-bicyclo[3.2.0]hept-2-ene 
• 128694-01-9 5-(2,3-dimethylbut-1-ene-3-yl)-1-(4-nitrophenyl)-3-phenyl-1,2,4-triazole 
• 128694-03-1 1-(4-Nitro-phenyl)-5-(1,1,2-trimethyl-allyl)-1H-[1,2,4]triazole-3-carboxylic acid methyl ester 
• 128694-04-2 5-ethoxy-4-(p-nitrophenyl)-2-phenyl-6,6,7,7-tetramethyl-1,3,4-triazabicyclo<3.2.0>hept-2-ene 
• 128694-08-6 5-(ethylthio)-4-(p-nitrophenyl)-2-phenyl-6,6,7,7-tetramethyl-1,3,4-triazabicyclo<3.2.0>hept-2-ene 
• 128694-10-0 5-Ethylsulfanyl-6,6,7,7-tetramethyl-4-(4-nitro-phenyl)-1,3,4-triaza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid methyl ester 
• 128694-05-3 2-(4-Chloro-phenyl)-5-ethoxy-6,6,7,7-tetramethyl-4-(4-nitro-phenyl)-1,3,4-triaza-bicyclo[3.2.0]hept-2-ene 
• 128694-06-4 5-Ethoxy-6,6,7,7-tetramethyl-2,4-bis-(4-nitro-phenyl)-1,3,4-triaza-bicyclo[3.2.0]hept-2-ene 
• 90886-53-6 2,2,3,3-Tetramethyl-β-alanin-methylester 

Relevant academic research and scientific papers

A New Approach Using Aromatic-Solvent-Induced Shifts in NMR Spectroscopy to Analyze β-Lactams with Various Substitution Patterns

The chemical shifts of protons depend not only on the properties of the solute molecule but also on the medium in which the solute resides. A series of β-lactams with various substitution patterns were synthesized to study aromatic-solvent-induced shifts

Tuning the biological activity profile of antibacterial polymers via subunit substitution pattern

Binary nylon-3 copolymers containing cationic and hydrophobic subunits can mimic the biological properties of host-defense peptides, but relationships between composition and activity are not yet well understood for these materials. Hydrophobic subunits i

PARTIALLY SATURATED NITROGEN-CONTAINING HETEROCYCLIC COMPOUND

There are provided compounds having a superior PHD2 inhibitory effect that are represented by general formula (I'): (in the above-mentioned general formula (I'), W, Y, R2, R3, R4, and Y4 are as described hereinabove), or pharmaceutically acceptable salts thereof.

Method for producing 3,3,4,4-tetramethyl-2-azetidinone

The present invention provides a method for producing 3,3,4,4-tetramethyl-2-azetidinone comprising removing a chlorosulfonyl group from 1-chlorosulfonyl-3,3,4,4-tetramethyl-2-azetidinone using an alkali compound in the presence of a phase transfer catalyst, which has excellent operability and high yield and provides easy treatment of the waste liquid.